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EDITORIAL REVIEW
Molecular properties of amiloride action and of its Na
transporting targets
Amiloride (Fig. 1) was originally synthesized at Merck, Sharp
and Dohme during the search for a nonsteroidal saliuretic agent
with antikaliuretic properties. Amiloride administered to dog,
rat and human results in modest increases in the urinary
excretion of sodium and bicarbonate, while causing a striking
reduction in the excretion of potassium. It is used as a diuretic
mostly in combination with hydrochiorothiazide in the treat-
ment of hypertension and congestive heart failure. Its clinical
advantage over more potent diuretics, such as furosemide and
ethacrynic acid, is that it prevents hypokaliemia to occur.
Amiloride acts at two distinct segments of the nephron. It
inhibits the Na4/H4 exchange system of the proximal tubule
and the epithelial Na4 channel of the distal tubule. Early studies
on the action of amiloride have been reviewed by Benos [1].
This review summarizes recent work aimed at defining in
molecular terms the action of amiloride on its two targets.
Extrarenal effects of amiloride are also considered in relation to
the cardiovascular system.
Amioride and the Na/H4 exchange system
The first description of the presence in rat renal, brush border
membrane vesicles of a coupled exchange of Na4 for H4 is due
to Murer, Hopfer and Kinne [2]. It was subsequently shown
that this exchange is inhibited by amiloride [3].
The main function of the N&7H4 exchanger of the renal
proximal tubule is to acidify the glomerular filtrate and hence to
promote the reabsorption of most of the filtered bicarbonate [4].
Protons released into the lumen titrate HC03 to carbonic acid
and CO2 which then diffuses across the apical membrane.
HC03 is regenerated inside the cells by carbonic anhydrase,
thus leading to the accumulation of HC03 against its electro-
chemical gradient. HC03 is then secreted at the basolateral
membrane by passive diffusion or using coupled transport
mechanisms involving Na4 and Cl- [4]. On the other hand Na4
that has entered the cells is transported to the blood by the
(Na,K4)ATPase. The asymmetric distribution of the different
ion transport pathways in the proximal tubule epithelium is
essential for vectorial transport of Na4 and bicarbonate (Fig. 2).
Both physiological and biochemical experiments showed that
the Na4/H4 exchange system is preferentially localized in the
apical membrane of the proximal tubule epithelium, whereas
the (Na4 ,K)ATPase is localized in the basolateral membrane
[6—9]. Physiological experiments [5] do, however, indicate that
the Na/H exchange system is also present in the basolateral
membrane of salamander proximal tubular cells.
The Na4/H exchange system is not only present in kidney
proximal tubular cells. It has now been identified in most
eukaryotic cells. It is involved in the regulation of the intracel-
lular pH, of the intracellular concentration of Na and of the
cell volume. It plays an important role during the progression of
the cells from the GJG1 phase to the S phase of the cell cycle.
These topics have been recently reviewed [4, 10—18].
The mechanistic properties of the renal Na/H4 exchange
system have been reviewed recently [10]. They can be summa-
rized as follows:
1. The system is electroneutral with a 1: 1 stoichiometry.
2. Only Li and Na4 and possibly NH44 can be exchanged for
H4. Guanidinium ions are antagonists of the system [19].
3. The antiport is reversible. However under physiological
conditions, the inward Na4 gradient across the apical mem-
brane imposes the system to function as an uptake pathway
for Na4 and as an effiux pathway for H4.
4. The interaction of the Na4/H4 exchanger with external Na4
and Li follows simple Michaelis—Menten kinetics [20]. Li4
presents a better affinity (KLI4 = 1 to 2 mM) for the antiport
than Na (KNa4 = 5 to 10 mM). However, the maximal rate
of Li/H4 exchange is lower than the maximum rate of
Na4/H exchange.
5. An increase of the external pH increases the activity of the
Na4/H4 exchanger. The upper panel of Figure 3 shows that
the external pH dependence of the Na4/H4 exchanger is
identical in rabbit kidney, brush border membranes and in
chick cardiac cells. In the kidney external H4 behaves as a
competitive inhibitor of Na4 uptake. This property allows
the kidney to adjust tubular HC03 reabsorption to the
luminal HC03 concentration [4]. In non-renal cells external
W behaves either as a non-competitive inhibitor of Na4
uptake (such as, chick skeletal muscle-cells [21] and rat brain
synaptosomes [22]) or as a mixed type inhibitor (such as
Chinese Hamster Fibroblasts [231 and peripheral blood lym-
phocytes [24]).
6. An intracellular acidification activates the Na4/H4 exchange
system. Internal H4 ions interact cooperatively with the
Na4/H4 exchanger [25], suggesting the presence of more
than one internal binding site for H4. This property has
important physiological consequences. A slight change in
the value of the intracellular pH produces a much larger
change in activity of the transporter for a cooperative system
than for a system that follows simple Michaelis-Menten
kinetics. Two extreme cases have been encountered. In
kidney brush border membranes the cooperativity in the
Na4/H4 exchange system is low. Hill coefficients describing
the interaction of internal H4 with the exchanger are be-
tween 1.2 and 1.3 [8, 26—28]. A much higher degree of
cooperativity is observed in cardiac cells [31], skeletal
muscle cells [29, 30], and brain synaptosomes [22], with
values of the Hill coefficient comprized between 2.5 and 3.0.
The lower panel of Figure 3 compares the internal pH
dependence of the Na4fH exchanger in rabbit renal, brush
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Fig. 1. Structural formula for amiloride and selected amiloride
derivatives.
border membranes and in muscle cells of cardiac and skel-
etal origins. It shows that the range of intracellular pH values
at which the antiport is active differs in renal cells and in
muscle cells. The pHi value at which the Na/H exchanger
is half maximally activated is close to 6.2 in renal brush
border membranes. It is 7.4 in muscle cells. The difference in
the pHi dependence of the antiport in the two cell type is
likely due to different extent of phosphorylation by protein
kinase C. The muscle form of the Na/W antiport has been
suggested to correspond to exchangers that are permanently
phosphorylated by protein kinase C [30, 32]. Conversely the
activity of the renal Na/H exchanger is increased by
activators of protein kinase C such as phorbol esters [33]. Its
unique properties of interaction with internal H might
correspond to exchangers that are not phosphorylated by
protein kinase C.
In some cell types, but not all, the internal pH and external pH
dependences of the Na/H exchange system are interdependent
[22, 34]. As a consequence, the activity of the Na/H exchanger
is controlled by the value of the transmembrane pH gradient in
addition to the intracellular and extracellular pH values.
The half maximum effect for amiloride inhibition of the
Na/H exchange system, measured at a low Na concentra-
tion, was observed at 25 pM in rabbit cortical, brush border
membranes [3, 35, 36] and in intact renal, proximal tubular cells
[37]. Amiloride has been reported to behave as a competitive [3]
or as a mixed type inhibitor of Na uptake [36]. In non-renal
cells the apparent affinity for amiloride is slightly higher (IC =
2 to 5 pM) and amiloride behaves as a competitive inhibitor of
Na uptake. As a consequence the apparent affinity for amil-
oride is shifted to higher concentrations under physiological
conditions of extracellular Na concentration and millimolar
concentrations of amiloride (that are unlikely to be attained in
vivo) are then required to inhibit the exchanger.
Amiloride is not the best inhibitor of the Na/W exchange
system. The presence of carbon chains on the five amino
position of the pyrazine ring of amiloride increases the blocking
potency of the molecule. The best compound found so far is N-S
ethylisopropylamiloride (Fig. 1). It can be as much as 200 times
more potent than amiloride [19, 38, 39]. Conversely substitution
of one of the hydrogen of the guanidino moiety of the amionde
structure drastically reduced the inhibiting potency of the
molecule. For instance benzamil, a potent inhibitor of the
amiloride-sensitive epithelial Na channels, is much less active
than amiloride for inhibiting the Na/H exchanger [39]. The
upper panel of Figure 4 illustrates the pharmacological proper-
ties of the Na/H exchanger in MDCK cells. The relative
potencies of different amiloride derivatives are very similar in
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Fig. 2. The two sites of action of amioride on the kidney.
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Fig. 3. Interaction of the Na/H exchanger with external and inter-
nal pH. A. The external pH dependence of the Na/H exchange
system in rabbit kidney brush border membranes (•) and in cardiac
cells (0). B. The internal pH dependence of the Na/H exchange
system in rabbit kidney brush border membranes (•), in chick cardiac
cells (s), and in chick skeletal muscle cells (0).
renal and non-renal cells [19, 22, 35, 37, 39—43]. Yet the Na/H'
exchanger of kidney brush border membranes and of proximal
tubular cells seems to be less sensitive to the inhibition by
amioride and amiloride derivatives than the Na/H exchanger
of non-renal cells [35, 37]. High sensitivities similar to those of
non renal cells have been reported for MDCK cells [35] (Fig. 4)
and LLC-PK1 cells [41]. It may be that the difference between
renal and non-renal tissues results from the experimental con-
ditions that have been used to measure the activity of the
Na/H exchange system [35]. It may also be that different
isotypes of the Na/H exchanger with different affinities for
amioride and its derivatives are present in renal and non-renal
tissues. Different isoforms of other cation transporting systems
such as the ouabain sensitive (Na, K)ATPase [44—46] and the
tetrodotoxin sensitive, voltage dependent Na channels [47, 48]
have already been described.
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Fig. 4. Pharmacological profiles of the amiloride sensitive cation
transporting systems: A. The NaVH antiport of MDCK cells. B. The
Na channel from pig kidney outer cortex membrane vesicles. C. The
Na+/Ca2± antiport of chick cardiac cells. Compounds shown are
amiloride (A in the two upper panels, • in lower panel), ethylisopro-
pylamiloride (•), benzamil (•), phenamil (V), and dichlorobenzamil
(0).
Inhibition of the Na/H exchanger is not limited to mole-
cules of the amiloride series. Harmaline and quinidine have also
been reported to inhibit the renal Na/H exchanger but with a
lower potency than amioride [20, 49]. Guanochlor, a molecule
with antihypertensive properties that is devoid of saliuretic
activity, inhibits both the renal and non-renal Na/H exchang-
ers with a two- to fivefold greater potency than amioride [191.
Two evidences indicate that the Na/II exchange system is
likely to be a membrane protein: (1) the activity of the Na/H
exchange system can be inhibited by histidine, carboxyl and
sulthydryl specific reagents [50, 51],and (2) in Chinese-Hamster
lung fibroblasts the activity of the Na/H exchange system is
either decreased or increased by mutation [52—54]. However the
transport protein has not yet been identified. A first step in this
direction consists, of course, in using amiloride derivatives as
markers of the NafH antiport. A tritium labelled derivative of
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amiloride (PH] ethylpropylamiloride) has been synthesized
[35]. Due its hydrophobic properties, [3H] ethylpropylamiloride
(EPA) cannot be used to titrate amioride binding sites in intact
membranes. However, specific and high-affinity [3H] EPA
binding sites were identified in solubilized rabbit, renal micro-
villus membranes [8, 35] and in rat brain synaptosomes [22].
Competition experiments between unlabelled amiloride denva-
tives and [3H] EPA have shown that these solubilized receptors
have the same pharmacological properties as those found from
22Na transport studies [22, 35]. As expected, [3H] EPA binding
sites are preferentially localized at the apical face of the renal
epithelium [8]. PH] EPA binding to solubilized renal Na/H
exchangers is antagonized by H, but not by Na and Li.
These results suggest that Na and Li, although they are
competitive inhibitors of amiloride action in 22Na transport
studies, bind in fact to a site that is distinct from the amiloride
binding site. The negative control of amioride binding by Na
and Li probably occurs via a conformational change within the
antiport protein which exists in the intact membrane and which
disappears after solubilization [8].
The activity of Na/H exchange system is modulated by a
variety of stimuli. Effectors are distinguished according to both
the time course of their effects and their action on the biochem-
ical properties of the system. Some stimuli (such as, mitogens,
phorbol esters and osmotic cell shrinking) produce an almost
immediate activation of the antiport. Other stimuli take hours or
days to activate the Na/H exchanger and are probably
effective on the biosynthesis of the Na/H antiport. The slow
type of activation occurs mainly in the kidney. The Na/H
exchange system of renal proximal tubules is hormonally con-
trolled by both circulating levels of thyroxine [551 and gluco-
corticoids [27, 56]. Pathophysiological states such as long-term
metabolic acidosis [26, 57—59], chronic renal failure [60—62],
high protein diets [63] and low K diets [64] are accompanied
by an increased activity of the Na/H exchanger. The kinetic
properties of the kidney Na/H exchanger after long-term
activation have been determined [8, 26—28, 62], and in all cases
it was found that activation was not accompanied by a modifi-
cation in the kinetic properties of the system. It could be
achieved either by increasing the density of antiports at the
surface of the cells [63] or by increasing the turnover rate of
pre-existing transporters [8].
In non-renal cells, short-term activating mechanisms of the
Na-/H exchanger prevail. In recent reviews, Moolenaar [16],
and Grinstein and Rothstein [13] have listed the different
short-term effectors of the Na/H exchanger in non-renal
cells. In contrast to long-term inducers, short-term inducers act
by modifying the kinetic properties of the system, possibly
through a phosphorylation of the antiport protein by protein
kinases. Three distinct modes of activation of the antiport have
been described:
Mode 1. Activation is produced by shifting the internal pH
dependence of the system to more alkaline pHi values. It is
observed following an activation of protein kinase C by phorbol
esters, by hormones and by growth factors that activate the
turnover of phosphatidylinositol [30, 64—67].
Mode 2. Activation also results from an increased maximum
velocity of the system with no change of the pHi dependence. It
was observed after stimulation of rat sk letal myoblasts by
serum and by epidermal growth factor under conditions in
which epidermal growth factor did not stimulate the breakdown
of inositol phospholipids [30].
Mode 3. Activation is produced in some cell types by
modifying both the internal and external pH dependences of the
system. This type of activation was observed after osmotic
shrinking of astrocytes [34]. Activation of the Na/H ex-
changer by osmotic shocks is not mediated by protein kinase C
[34, 68].
Recent reports suggest that short term inducers also act on
the renal Na/H exchange system. Fine et al [69] showed that
insulin and prostaglandin E, stimulated the Na/H exchanger
in quiescent primary cultures of rabbit renal, proximal tubular
cells and suggested that this stimulation could be an early event
in the development of cell hypertrophy in response to subtotal
nephrectomy. Mellas and Hammerman [33] showed that phor-
bol esters are able to activate the Na/W exchanger and induce
an alkalinization of canine, proximal tubular cells. Finally
parathyroid hormone inhibits the renal Na/H exchanger [70,
71]. This effect might be the mechanism by which parathyroid
hormone decreases bicarbonate reabsorption by the proximal
tubule [72—74]. The action of parathyroid hormone on the
Na/H exchanger seems to be mediated by an increase in
intracellular cAMP levels.
Amiloride and the epithelfal Na channel.
The second important target of amiloride is localized at more
distal parts of the kidney tubule. There, the first step of the
transepithelial movement of Na is due to Na influx down its
electrochemical gradient across the apical membrane through
high conductance Na channels (Fig. 2). Following the demon-
stration by Eigler, Kelter and Renner [75] that amiloride inhib-
ited Na transport across frog skin, amiloride-sensitive epithe-
hal Na channels have been extensively studied in amphibian
epithelia using short-circuit current techniques, 22Na uptake
experiments and electrophysiological techniques [reviewed in
76—78].
The single channel properties of the Na channel from rat,
cortical collecting tubule have recently been determined using
the patch clamp technique [79]. The single channel conductance
is 5 picoSiemens at 140 mM Na, meaning that open conforma-
tion of Na channels allow the net transfer of greater than 106
Na ions per second. In comparison the turnover number of the
Na/H exchange system has been estimated to be of about
2500 Na1 ions per second [80]. Epithelial Na channels are
selective for Na over K. They show spontaneous transitions
between an open state and a closed state, each state having a
mean open time of three to four seconds. Amiloride produces a
flickering of the channel, that is, it produces more frequent
opening and closing of the channel and a reduction of the mean
open time. Amiloride did not change the conductance of the
open state of the channel. This effect is similar to that observed
for the blockade of voltage dependent Na channels in excit-
able tissues by local anaesthetics. Single channel properties of
Na channels in frog epithelia were also determined using noise
analysis [76], reconstitution experiments in lipid bilayers [80]
and the patch clamp technique [81]. Although epithelial Na
channels from amphibia and mammals differ in some respect
[77], they are clearly distinct from the Na channels which are
responsible for the generation of action potentials in excitable
cells. Both types of channels have a large conductance state,
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they are selective for Na over K. However, epithelial and
excitable cells Na channels have both distinct pharmacologi-
cal properties and voltage dependences. The excitable cell Na
channel is very voltage dependent, whereas the epithelial Na
channel is not significantly. Tetrodotoxin blocks Na channels
of excitable cells and is without effect on epithelial Na channels.
Amiloride, at concentrations lower than 1 M blocks epithelial
Na channels without affecting voltage dependent Na chan-
nels. The single channel conductance of epithelial Na channels
saturates with increasing Na concentration, whereas the con-
ductance of Na channels from excitable tissues does not.
Finally, the two types of Na channels have very different
mean opening times: a few milliseconds for the Na channel of
excitable cells, 40 mseconds to 5 seconds for the epithelial Na
channel. A prolonged opening of the epithelial Na channel
ensures the reabsorption of significant amounts of Na by the
distal tubular epithelium.
Epithelial Na channels are more sensitive to the inhibition
by amiloride than the Na/H exchanger. The half maximum
inhibition of the Na channel by amiloride was observed at 70
n in the rabbit renal, cortical collecting tubule [82] and to 50 to
500 n in amphibian epithelia [83—85]. In amphibian epithelia,
amiloride behaves as a competitive or a non-competitive inhib-
itor of Na uptake depending on the species [reviewed in 1].
Structure activity relationships of amiloride derivatives in rela-
tion with epithelial Na channel blockade have been studied
using adrenalectomized rats [86], isolated frog skins [87—90] and
also membrane vesicles isolated from mammalian kidneys [91,
92]. The most important finding from these studies is that the
acylguanidine moiety of amiloride is the least sensitive to
chemical modifications. This clearly distinguishes the Na
channel from the Na/H exchanger. Substitution of one of the
hydrogen atoms of the guanidino group of the amiloride mole-
cule by a benzyl or a phenyl group drastically increases the
potency of the molecule. For instance benzamil (Fig. 1) is up to
18 times more potent than amiloride for inhibiting the Na
channel in frog skin. It is also more potent than amiloride for
inhibiting Na channels in renal membrane vesicles [91, 92].
Phenamil (Fig. 1) is an even more potent inhibitor of the Na
channel than benzamil both in frog skin [93] and in pig renal
membrane-vesicles [92]. The other important point revealed by
analysis of structure activity relationships is that amiloride
analogues that bear substituents on the five amino group, which
are much more potent than amiloride for inhibiting the Na/H
exchange system, are usually inactive on epithelial Na chan-
nels. The middle panel of Figure 4 presents typical data
describing the pharmacological sensitivity of epithelial Na
channels of pig kidney membranes to amiloride and amiloride
analogues.
Although the pharmacological profile of Na channels is very
similar in different species, estimates of the affinity for amil-
oride or its derivatives differ widely in different studies. For
instance, in amphibian epithelia, the IC50 for amiloride inhibi-
tion of the short circuit current due to Na channel activity was
found to be between 50 n and 500 nM. 22Na uptake experi-
ments performed on toad bladder membrane-vesicles have
suggested the presence of two different amiloride sensitive Na
uptake pathways with IC50 values for amiloride inhibition of 60
n and 6 ILM, respectively [94]. In the mammalian kidney, the
IC50 for amilonde inhibition of the short circuit current was
Table I. Summary of [3H]benzamil and [3H)phenamil binding studies
on various kidney membrane preparations
Species
ic Maximum binding50
capacity pmol/mg
Benzamil flM Amiloride M of protein
Rat 40 10 62
Guinea pig 71 4 93
Rabbit 6 3 77
Chick 77 8 47
Frog 141 20 70
Bovine 4 0.4 130
Pig 300 4 11
IC50 for benzamil and amiloride were determined from competition
experiments between [3H]benzamil or [3H]phenamil and unlabelled
benzamil and amiloride. Results presented are from Cuthbert and
Edwardson [98], Kleyman et al [91], and Barbry et al [92].
estimated to 70 nM [82]. Yet amiloride inhibition of 22Na
uptake by isolated kidney membrane-vesicles and amiloride
inhibition of radiolabelled ligand binding were observed be-
tween 0.4 iM and 10 M (Table 1). The reasons for such
variations are not yet clear [1, 94, 95].
Radiolabelled amiloride and amiloride derivatives constitute
probably potent pharmacological probes to identify and even-
tually purify epithelial Na channels. Cuthbert and Shum [96]
were first to attempt the titration of the amiloride binding sites
in frog skin using ['4C] amiloride. However both the low
specific radioactivity of the molecule and the low density of
binding sites made it difficult to successfully use the labelled
compound. Much better results have been obtained with [3H]
labelled derivatives of amiloride. A number of such molecules
have been synthesized: [3H] benzamil [91, 97, 98], [3H] 6-
bromomethylamiloride [99, 100], and [3H] phenamil [92, 101].
Tritiated amiloride derivatives bind with a high affinity to
specific binding sites. Binding is reversible, saturable and it can
be protected or displaced by unlabelled amiloride or amiloride
derivatives. The order of potency for the inhibition by amiloride
derivatives of the specific binding of either [3H] benzamil or
[3H] phenamil correlates with the order of potency for the
inhibition of the Na channel [91, 92, 98]. One use of labelled
amiloride derivatives is to estimate the density of Na chan-
nels. The various estimates that have been obtained to date are
listed in Table 1. Large variations are observed from one
species to another. Lower estimates of channel densities were
determined by noise analysis probably because binding studies
titrate both open and closed forms of the channel while elec-
trophysiological experiments measure only open forms of the
channel. Six-bromo derivatives of amiloride derivatives can be
used as affinity labels. They covalently bind to the epithelial
Na channel. Six-bromoamiloride [93, 102] and 6-bromometh-
ylamiloride [99] have been shown to irreversibly inhibit Na
transport across frog skin after UV irradiation. Long exposures
to phenamil also seem to produce an irreversible blockade of
the Na channel [93]. Finally, Kleyman et a! [91] UV irradiated
bovine kidney cortex membrane-vesicles exposed to [3H] bro-
mobenzamil and observed the covalent labelling of three poly-
peptide chains with Mr 176,000, 77,000 and 47,000. This cova-
lent incorporation was prevented by a large excess of unlabelled
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amiloride or benzamil, which suggested that these three poly-
peptide chains are components of the epithelial Na channel.
The epithelial amiloride-sensitive Na channel of both am-
phibia and mammalian species is under the control of both
aldosterone and vasopressin. These topics have been reviewed
recently [77, 1031. Aldosterone stimulates Na reabsorption
possibly through a methylation of pre-existing silent channels
[104, 105]. Vasopressin, which stimulates Na reabsorption,
produces an increase in intracellular cAMP concentration,
increases the density of Na channels at the apical membrane
with no apparent change of the single channel conductance
[1061. Vasopressin may favor either the opening of silent
channels already inserted into the membrane [1071 or the
insertion of channels from a nonmembrane pool [1041.
The cardiovascular action of amiloride
Therapeutic levels of amiloride reduce digitalis sensitivity of
the heart [108—113]. Amiloride protects the heart against toxic
effects of digitalis in rodents and humans by delaying the onset
of cardiac arrhythmias [110, 1111. A direct action of amilonde
on digitalis effects in isolated cardiac preparations was also
documented [39, 114—118].
The mechanism by which digitalis exerts its positive inotropic
effect includes a cascade of events. First digitalis inhibits the
cardiac (Na,K)ATPase leading to a rise of the intracellular
Na concentration ([Na]i). As a result, the activity of the NaI
Ca2 exchange system is modified and more calcium becomes
available for contraction [43]. When high intracellular Na and
Ca2+ levels are attained at higher digitalis concentrations,
arrhythmias develop [119].
Incubation of cardiac cells in culture with ouabain produces a
rise in [Na]i and the uptake of Ca2 by the Na/Ca2 exchange
system [44, 1201. In cardiac cells, the Na/H exchange system
turns out to be one major Na entry system in charge of the
regulation of the internal Na concentration [40]. Therefore,
the increase in internal Na concentration which is produced by
ouabain or other digitalis compounds when they inhibit the
major Na efflux pathway, the (Nat ,K)ATPase, is prevented
when, at the same time, amiloride or its derivatives inhibit the
major Na entry pathway, the Na/H exchange system [40,
117].
Ouabain induces the uptake of calcium by the NaICa2
exchange system in response to an increase in the intracellular
Na concentration. This increase is also antagonized by amilo-
ride and N-S disubstituted derivatives of amiloride with prop-
erties that suggest that the primary effect of amiloride on
calcium uptake is to inhibit the Na/H exchange system [40].
Amiloride derivatives such as benzamil and dichlorobenzamil
(Fig. 1) have almost no action on the Na/H* exchange system.
Yet they inhibit the Na/Ca2 exchange system [121—124]. The
lower panel of Figure 4 presents the pharmacological properties
of the Na/Ca2 exchange system in chick cardiac cells. Half
maximum inhibition of the NaICa2 exchanger by benzamil is
observed at about 0.1 ma'i. It is observed at much lower
concentrations for the epithelial Na channel (Table 1). Figure
4 shows in addition that one can use concentrations of amiloride
and benzamil which completely block Na channels without
affecting the Na/Ca2 exchange system. The most active
inhibitors of the Na/H exchanger are without effect on the
Na/Ca2 exchange at concentrations lower than 1 mrvi [122].
The best compound found so far to inhibit the Na/Ca2
exchange system is dichlorobenzaniil (IC50 = 40 .M).
Other effects of amiloride
Amiloride also affects a number of cellular activities. It
blocks protein synthesis in whole cells and in cell free systems
[41, 125, 126]. It inhibits the activity of the (Na ,K)ATPase
[42, 127, 128] and of several protein kinases [129—131]. How-
ever, all these effects have been observed with very high
concentrations of amiloride and are relatively insensitive to
modifications of the amiloride structure [42; however ref. 43 has
a different result}. Conversely, both the epithelial Na channel
and the Na/H exchange system are inhibited by low concen-
trations of selected amiloride derivatives and the inhibitory
effect is highly sensitive to small modifications of the chemical
structure of the molecule. The intracellular effects of amiloride
and its derivatives are probably due to their weak base proper-
ties which allow this class of molecule to rapidly penetrate into
cells and accumulate into acidic compartments [132].
Conclusion
Benos in his 1982 review on amiloride [1] concluded that the
molecule would probably become "a molecular probe for the
ultimate understanding of many basic cellular functions." The
present review, which analyzes more recent literature, fully
confirms this conclusion. Probably the most important obser-
vation made in recent years is that several Na transporting
systems are sensitive to amiloride and can be distinguished
according to their sensitivity to selected amiloride derivatives.
It is clear now that amiloride derivatives such as ethylisopro-
pylamiloride on one hand and benzamil and phenamil, on the
other hand, are far more potent inhibitors than amiloride for
inhibiting the Na/H antiport and the epithelial Na channel,
respectively. Undoubtly they are essential tools for attempting
the purification of both the Na/H exchange system and the
epithelial Na channel and for understanding their molecular
mechanisms and their multiple regulations.
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Note added in proof
While this review was submitted, two reports have been published on
the structure of the epithelium Na channel. First Benos et al, using
[3H]methylbromoamiloride purified a 730 kD protein from cultured A6
cells and bovine renal papilla. Upon reduction this protein was resolved
into five polypeptide chains (315 kD, 150 kD, 95 kD, 71 kD, and 55 kD).
Photoaffinity labelling experiments further indicated that the 150 kD
polypeptide chain binds amiloride. On the other hand Barbry et al,
using [3H]phenamil, purified a 185 kD protein from pig kidneys. Under
reducing conditions, it was resolved into a single 105 kD polypeptide
chain. Reconstitution experiments indicate that the purified 185 kD
protein is able to catalyze amiloride sensitive electrogenic Na
transport.
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